IgA nephropathy (IgAN) is characterized by the deposition of IgA1-containing immune complexes in the glomerular mesangium. The pathogenesis follows a 4-hit cascade: ...

Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...

IgA nephropathy is the leading cause of kidney failure. Around half of those with IgA nephropathy will see worsening kidney function over many years. For some people, this happens more quickly.

Though not everyone with IgA nephropathy deals with end-stage kidney disease, around 25% of them face this complication. But there may be another option: a clinical trial. Depending on what’s ...

The FDA has given breakthrough therapy designation to OMS721, a new treatment for the rare kidney disease immunoglobulin A (IgA) nephropathy. The news is a major boost for Seattle-based Omeros ...

Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353 , 883–887 (1999). Article CAS Google Scholar ...

Living with the rare condition of IgA nephropathy can feel lonely. Patient advocate Stuart Miller shares his treatment journey and how to stay connected with those who understand. Share on ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA) nephropathy, maker Novartis announced late on Wednesday.

Expanding Global Support: IgA Nephropathy Foundation Launches Go Global Network to Connect and Empower IgAN Patients Worldwide. By expanding our network to Canada, we are building a stronger ...

Immunoglobin A nephropathy (also known as IgAN or Berger's disease) is a rare kidney disease that occurs when your immune system mistakenly attacks the kidneys and produces excess IgA (a type of ...

Our extensive research on the Global IgA Nephropathy Disease Treatment Market (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, investment ...